Get the latest Science News and Discoveries
Nasal COVID-19 Vaccine Secures Federal Funding for Groundbreaking Clinical Trial
The trial will evaluate the effectiveness and safety of a new vaccine compared to an FDA-approved mRNA vaccine. University of Georgia-based startup CyanVac LLC has received federal funding to conduct a Phase 2b clinical trial to compare its intranasal vaccine candidates, CVXGA, which are designed t
None
Or read this on SciTech Daily
